Literature DB >> 21919063

Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection.

Fazilet Duygu1, Suda Tekin Koruk, Nurten Aksoy.   

Abstract

The aim of this study was to determine and evaluate the activity of paraoxonase and arylesterase enzymes in various clinical forms of hepatitis B infection and to investigate the correlation between these parameters and chronic disease course/fibrosis. Overall, 40 patients diagnosed as hepatitis B carriers (CIHBV), 40 chronic active hepatitis B (CAHBV) patients, and 40 healthy adults (control group) between 18 and 65 years of age were enrolled the study. Serum paraoxonase and arylesterase activities were measured spectrophotometrically. Their activities were significantly lower in patients with CAHBV compared with CIHBV patients or with control group patients (P<0.001). There was a negative correlation between alanine aminotransferase levels and the activity of paraoxonase and arylesterase (r = -0.38, P = 0.001 and r = -0.28, P = 0.002, respectively). A statistically significant negative correlation was found between arylesterase activity in the sera of CAHBV patients and HBV DNA levels (ρ = -0.33, P = 0.03). On the contrary, no correlation was found between paraoxonase levels and HBV DNA levels (P>0.05). The histology activity index of CAHBV patients did not correlate with paraoxonase and arylesterase activities (P>0.05). In light of these findings, it may be assumed that during the progression of an inactive hepatitis B carrier to being actively infected, reduced paraoxonase and arylesterase activities may be observed.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21919063      PMCID: PMC6647572          DOI: 10.1002/jcla.20473

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

1.  Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairment.

Authors:  Jordi Camps; Judit Marsillach; Jorge Joven
Journal:  Clin Chim Acta       Date:  2007-07-25       Impact factor: 3.786

2.  Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage.

Authors:  Natàlia Ferré; Jordi Camps; Eduard Prats; Elisabet Vilella; Antoni Paul; Lídia Figuera; Jorge Joven
Journal:  Clin Chem       Date:  2002-02       Impact factor: 8.327

3.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

4.  Why plasma should not be used to study paraoxonase.

Authors:  M I Mackness
Journal:  Atherosclerosis       Date:  1998-01       Impact factor: 5.162

5.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  H W Eckerson; C M Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

6.  Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis.

Authors:  Gulden Baskol; Huseyin Demir; Mevlut Baskol; Eser Kilic; Filiz Ates; Derya Kocer; Sabahattin Muhtaroglu
Journal:  Clin Biochem       Date:  2005-10       Impact factor: 3.281

7.  Genetic variations of the paraoxonase gene in patients with coronary artery disease.

Authors:  S H Hong; J Song; W K Min; J Q Kim
Journal:  Clin Biochem       Date:  2001-09       Impact factor: 3.281

8.  Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.

Authors:  Mehmet Aslan; Yasar Nazligul; Mehmet Horoz; Cengiz Bolukbas; Fusun F Bolukbas; Mustafa Gur; Hakim Celik; Ozcan Erel
Journal:  Atherosclerosis       Date:  2006-11-27       Impact factor: 5.162

9.  The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.

Authors:  M I Mackness; C Abbott; S Arrol; P N Durrington
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

10.  Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.

Authors:  C E Furlong; R J Richter; S L Seidel; A G Motulsky
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

View more
  7 in total

1.  Serum paraoxonase and arylesterase activities in patients with chronic otitis media.

Authors:  Mahfuz Turan; Rıfkı Ucler; Mehmet Aslan; Ferhat Kalkan; Abdullah Taskın; Mehmet Fatih Garca; Hakan Cankaya
Journal:  Redox Rep       Date:  2015-05-13       Impact factor: 4.412

2.  Alteration of thiol-disulphide homeostasis in acute tonsillopharyngitis.

Authors:  Soner Sertan Kara; Ozcan Erel; Tugba Bedir Demirdag; Burcu Ceylan Cura Yayla; Belgin Gulhan; Salim Neselioglu; Meltem Polat; Gokhan Kalkan; Anil Tapisiz; Hasan Tezer
Journal:  Redox Rep       Date:  2016-04-20       Impact factor: 4.412

Review 3.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

Review 4.  Osteomyelitis, Oxidative Stress and Related Biomarkers.

Authors:  Luca Massaccesi; Emanuela Galliera; Antonio Pellegrini; Giuseppe Banfi; Massimiliano Marco Corsi Romanelli
Journal:  Antioxidants (Basel)       Date:  2022-05-27

5.  Low paraoxonase 1 activity predicts mortality in surgical patients with sepsis.

Authors:  Suzana Bojic; Jelena Kotur-Stevuljevic; Nevena Kalezic; Zorana Jelic-Ivanovic; Aleksandra Stefanovic; Ivan Palibrk; Lidija Memon; Zdravko Kalaba; Marina Stojanovic; Sanja Simic-Ogrizovic
Journal:  Dis Markers       Date:  2014-02-09       Impact factor: 3.434

6.  In Silico Discovery of Candidate Drugs against Covid-19.

Authors:  Claudia Cava; Gloria Bertoli; Isabella Castiglioni
Journal:  Viruses       Date:  2020-04-06       Impact factor: 5.048

Review 7.  High-Density Lipoproteins Are Bug Scavengers.

Authors:  Olivier Meilhac; Sébastien Tanaka; David Couret
Journal:  Biomolecules       Date:  2020-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.